Among the most successful fund investment fields, there are Chemical, Therapeutics. Among the various public portfolio startups of the fund, we may underline Pepscan Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The fund is generally included in less than 2 deals every year. The high activity for fund was in 2006. The common things for fund are deals in the range of 5 - 10 millions dollars.
The typical case for the fund is to invest in rounds with 3 participants. Despite the Biox Biosciences, startups are often financed by Wageningen Business Generator, Technofund Flevoland, PPM Oost NV. The meaningful sponsors for the fund in investment in the same round are Lupus Ventures, Technofund Flevoland, PPM Oost NV.
Related Funds
| Fund Name | Location |
| Airlines Reporting Corporation | Arlington, United States, Virginia |
| Besterra | Japan, Koto |
| Cooperathon | Canada, Montreal, Quebec |
| DevX | Ahmedabad, Gujarat, India |
| Diamond Bank | Lagos, Lekki, Nigeria |
| Direct Equity Partners | Georgia, Peachtree City, United States |
| Falconhead Capital | New York, New York, United States |
| Futailai Investment | - |
| Gen Pharmaceuticals | Ankara, Ankara, Turkey |
| Growth Ninjas GmbH | Austria, Vienna |
| Hildebrand Technology | - |
| International Vitamin | Freehold, New Jersey, United States |
| Jewellery Water | China, Shanghai |
| Keshif Ventures | California, San Diego, United States |
| Osprey Capital | Illinois, United States, Wilmette |
| Sandway Investment | - |
| Shanghai Fuyu Guanggao | Baoshan, China, Shanghai |
| SHINMEI | Japan, Tokyo |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Immunovo | 28 Apr 2010 | 's-Hertogenbosch, North Brabant, Netherlands | |||
Pepscan | $8M | 19 Sep 2006 | Lelystad, Flevoland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Immunovo | 28 Apr 2010 | 's-Hertogenbosch, North Brabant, Netherlands | |||
Pepscan | $8M | 19 Sep 2006 | Lelystad, Flevoland |
